(2010). Intravitreal bevacizumab (Avastin®) for diabetic retinopathy at 24-months: The 2008 Juan Verdaguer-planas lecture.
Chicago Style (17th ed.) CitationIntravitreal Bevacizumab (Avastin®) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-planas Lecture. 2010.
MLA (8th ed.) CitationIntravitreal Bevacizumab (Avastin®) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-planas Lecture. 2010.
Warning: These citations may not always be 100% accurate.